OPKO Health, Inc. Deferred Income Tax Liabilities, Net
OPKO Health, Inc. (OPK) had Deferred Income Tax Liabilities, Net of $108.23 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-28
- 2026-06-30: Deferred Income Tax Liabilities, Net $108.23M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $114.56M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $126.24M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $130.34M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $108.23M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $114.56M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $126.24M 10-Q/A · filed 2026-08-28 |
| 2025-09-30 | $130.34M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $113.33M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $129.44M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $140.80M 10-K · filed 2026-02-26 |
| 2024-09-30 | $128.41M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $119.12M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $121.64M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $126.77M 10-K · filed 2025-03-03 |
| 2023-09-30 | $138.01M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $133.05M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $129.67M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $126.43M 10-K · filed 2024-03-01 |
| 2022-09-30 | $135.07M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $176.74M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $125.03M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $148.49M 10-K · filed 2023-02-27 |
| 2021-09-30 | $134.25M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $136.42M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $135.24M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $137.21M 10-K · filed 2022-03-01 |
| 2020-09-30 | $119.18M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $118.98M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $118.60M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $118.72M 10-K · filed 2021-02-18 |
| 2019-09-30 | $113.48M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $113.33M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $116.01M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $115.19M 10-K · filed 2020-03-02 |
| 2018-09-30 | $134.11M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $148.25M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $148.73M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $148.73M 10-K · filed 2019-03-01 |
| 2017-09-30 | $118.80M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $142.21M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $159.29M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $165.33M 8-K · filed 2019-01-29 |
| 2016-09-30 | $184.49M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $207.59M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $202.68M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $226.04M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |